ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

被引：554

作者：

Yang, Jer-Yen ^{[1
,2
]}

Zong, Cong S. ^{[1
]}

Xia, Weiya ^{[1
]}

Yamaguchi, Hirohito ^{[1
]}

Ding, Qingqing ^{[1
]}

Xie, Xiaoming ^{[1
]}

Lang, Jing-Yu ^{[1
]}

Lai, Chien-Chen ^{[3
]}

Chang, Chun-Ju ^{[1
]}

Huang, Wei-Chien ^{[1
]}

Huang, Hsin ^{[1
,4
]}

Kuo, Hsu-Ping ^{[1
,2
]}

Lee, Dung-Fang ^{[1
,2
]}

Li, Long-Yuan ^{[3
,5
]}

Lien, Huang-Chun ^{[6
]}

Cheng, Xiaoyun ^{[1
,2
]}

Chang, King-Jen ^{[7
,8
]}

Hsiao, Chwan-Deng ^{[9
]}

Tsai, Fuu-Jen ^{[3
]}

Tsai, Chang-Hai ^{[3
,5
]}

Sahin, Aysegul A. ^{[10
]}

Muller, William J. ^{[11
,12
]}

Mills, Gordon B. ^{[13
]}

Yu, Dihua ^{[1
,2
]}

Hortobagyi, Gabriel N. ^{[14
]}

Hung, Mien-Chie ^{[1
,2
,3
,5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA

[2] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA

[3] China Med Univ Hosp, Taichung 404, Taiwan

[4] Univ Calif Davis, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA

[5] Asian Univ, Taichung 413, Taiwan

[6] Natl Taiwan Univ, Dept Pathol, Taipei 106, Taiwan

[7] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 106, Taiwan

[8] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 106, Taiwan

[9] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan

[10] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

[11] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada

[12] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada

[13] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

NATURE CELL BIOLOGY | 2008年 / 10卷 / 02期

关键词：

D O I：

10.1038/ncb1676

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The RAS-ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that ERK downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylated FOXO3a degrades via an MDM2-mediated ubiquitin-proteasome pathway. However, the non-phosphorylated FOXO3a mutant is resistant to the interaction and degradation by murine double minute 2 (MDM2), thereby resulting in a strong inhibition of cell proliferation and tumorigenicity. Taken together, our study elucidates a novel pathway in cell growth and tumorigenesis through negative regulation of FOXO3a by RAS-ERK and MDM2.

引用

页码：138 / U22

页数：17

共 50 条

[1] ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang
Cong S. Zong
Weiya Xia
Hirohito Yamaguchi
Qingqing Ding
Xiaoming Xie
Jing-Yu Lang
Chien-Chen Lai
Chun-Ju Chang
Wei-Chien Huang
Hsin Huang
Hsu-Ping Kuo
Dung-Fang Lee
Long-Yuan Li
Huang-Chun Lien
Xiaoyun Cheng
King-Jen Chang
Chwan-Deng Hsiao
Fuu-Jen Tsai
Chang-Hai Tsai
Aysegul A. Sahin
William J. Muller
Gordon B. Mills
Dihua Yu
Gabriel N. Hortobagyi
Mien-Chie Hung
Nature Cell Biology, 2008, 10 : 138 - 148
[2] Effect of ERK on tumorigenesis and on inhibition of FOXO3a via MDM2-mediated degradation
Yang, J.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[3] ERK promotes tumorigenesis by inhibiting FOXO3a via MCM2-mediated degradation (vol 10, pg 138, 2008)
Yang, J. Y.
Zong, C. S.
Xia, W. Y.
Yamaguchi, H.
Ding, Q. Q.
Xie, X. M.
Lang, J. Y.
Lai, C. C.
Chang, C. J.
Huang, W. C.
Huang, H.
Kuo, H. P.
Lee, D. F.
Li, L. Y.
Lien, H. C.
Cheng, X. Y.
Chang, K. J.
Hsiao, C. D.
Tsai, F. J.
Tsai, C. H.
Sahin, A. A.
Muller, W. J.
Mills, G. B.
Yu, D. H.
Hortobagyi, G. N.
Hung, M. C.
NATURE CELL BIOLOGY, 2008, 10 (03) : 370 - 370
[4] ERK and MDM2 prey on FOXO3a
Wensheng Yang
Nathan G. Dolloff
Wafik S. El-Deiry
Nature Cell Biology, 2008, 10 : 125 - 126
[5] ERK and MDM2 prey on FOXO3a
Yang, Wensheng
Dolloff, Nathan G.
El-Deiry, Wafik S.
NATURE CELL BIOLOGY, 2008, 10 (02) : 125 - 126
[6] HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53
Wang, Yuhong
Hu, Lin
Wang, Jian
Li, Xiangwei
Sahengbieke, Sana
Wu, Jingjing
Lai, Maode
JOURNAL OF PATHOLOGY, 2018, 246 (04): : 508 - 518
[7] FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation
Tomiyasu, Haruki
Habara, Makoto
Hanaki, Shunsuke
Sato, Yuki
Miki, Yousei
Shimada, Midori
CANCER SCIENCE, 2025, 116 : 232 - 232
[8] FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation
Tomiyasu, Haruki
Habara, Makoto
Hanaki, Shunsuke
Sato, Yuki
Miki, Yosei
Shimada, Midori
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (04)
[9] Akt activation promotes degradation of tuberin and FOXO3a via the proteasome
Plas, DR
Thompson, CB
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) : 12361 - 12366
[10] XPC promotes MDM2-mediated degradation of the p53 tumor suppressor
Krzeszinski, Jing Yan
Choe, Vitnary
Shao, Jia
Bao, Xin
Cheng, Haili
Luo, Shiwen
Huo, Keke
Rao, Hai
MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (02) : 213 - 221

← 1 2 3 4 5 →